15 November 2016 EMA/740943/2016 Human Medicines Research & Development Division

Enpr-EMA awareness webinar: Agenda and joining instructions 1 December 2016, 14:30 to 15:30 GMT

1. Agenda: Chair: Mark Turner, Irmgard Eichler Item

Preliminary draft agenda

Speaker

Mins

1.

Introduction of Enpr-EMA and role of EMA in Enpr-EMA

Irmgard

15’

Eichler 2.

Role of networks and what they can offer to industry

Mark

15’

Turner 3.

Q&A session

All

30’

2. Joining instructions Connection Test Link: It is recommended that you test your computer prior to attending a meeting. To do this, please click here. The Connection Test checks your computer to make sure all system requirements are met. If you wish to connect via a VPN (virtual private network) we recommend you test your connection in this environment. Should you have any issues accessing Adobe Connect via your VPN you should contact your system administrator.

How to login: Browse the following URL your web browser from the meeting invitation: https://connect.ema.europa.eu/application_programming/

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.

You will reach the log in screen and should select the option to Enter as a Guest, enter your full name (first name, surname and affiliation) then click on Enter Room. The meeting launches in your browser and the meeting room interface will appear. The maximum capacity of this webinar is 200 participants. Access is on extract first come first serves basis.

Listen via your computer speakers or telephone To follow the audio via your computer simply click on the button in the join audio conference window. Please ensure your computer speakers are turned on and that the volume level is up. The audio will automatically broadcast via your computer speakers and you can also plug in headphones or earphones to follow the audio. If you wish to connect via telephone select the Dial-out option, enter your telephone number in the full international format and click Join to receive a call from the system (you will be automatically muted).

How to post a question Questions will be taken in writing during the Q&A session as participants will not have speaking rights. Please post your query in the Meeting Chat window located on the centre left hand-side of the meeting room interface.

Enpr-EMA awareness webinar: Agenda and joining instructions EMA/740943/2016

Page 2/2

Enpr-EMA awareness webinar - European Medicines Agency

Nov 15, 2016 - How to login: Browse the following URL your web browser from the meeting invitation: https://connect.ema.europa.eu/application_programming ...

84KB Sizes 3 Downloads 275 Views

Recommend Documents

Enpr-EMA awareness webinar - European Medicines Agency
Nov 15, 2016 - conference window. Please ensure ... full international format and click Join to receive a call from the system (you will be automatically muted).

2nd International Awareness Session - European Medicines Agency
Dec 12, 2017 - Medicines Agency. EMA/779846/2017. Page 2/3. Day 1 - Thursday 8 March 2018. Time. Module / Topics. 08:45-. 09:00. Opening remarks and Official welcome. 09:00-. 10:00. 01 - Setting the scene: Introduction to the EU Regulatory. Network (

MAH'S webinar instruction - European Medicines Agency - Europa EU
virtual lobby until the meeting Host is ready to accept participants. Connecting your audio: ... Please contact the EMA Service Desk to enrol confirming the date you wish attend. •. On demand training video: ... For urgent meeting support please em

NCA's webinar instruction - European Medicines Agency - Europa EU
Jun 12, 2017 - EMA/381965/2017. Adobe Connect Invitation: Guest Access. Meeting URL: https://connect.ema.europa.eu/eudravigilance_project_ncas/. Password: EMA has circulated the confidential password to your respective member of PRAC, EV-EWG. NCAs me

Notice - European Medicines Agency
Apr 28, 2017 - 2. The United Kingdom will then become a 'third country'. 3. Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties. In view of the considerable uncertainties, in parti

Report - European Medicines Agency
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.

Human Medicines Highlights Newsletter - European Medicines Agency
Mar 8, 2018 - Treatment of uterine fibroids. Haematology. New medicines authorised. • Adynovi (rurioctocog alfa pegol). Treatment and prevention of bleeding in patients with haemophilia A. New information on authorised medicines. • Feraccru (ferr

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Treatment of cystine crystal deposits in the eye. New information on authorised medicines. Lucentis (ranibizumab) - change in indication. Treatment of visual ...

Human Medicines Highlights Newsletter - European Medicines Agency
The new EudraVigilance system and the electronic reporting of individual case ... the ISO/ICH E2B(R3) format: hands-on training course - October 2017 ... granted a conditional marketing authorisation on the basis of less complete clinical data ...

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Finasteride - European Medicines Agency - europa.eu
Apr 25, 2018 - Page 2/8. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the.

Agenda - European Medicines Agency - europa.eu
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

Human medicines highlights newsletter - European Medicines Agency
PCWP and HCPWP joint meeting - Sept 2016 - meeting documents. • Workshop on identifying opportunities for 'big data' in medicines development and ...

Human Medicines Highlights Newsletter - European Medicines Agency
Used for the management of hypovolaemia (low blood volume) caused by acute (sudden) blood loss .... EMA's Business Continuity Plan for Brexit published.

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a ... Withdrawal of applications for new medicines .... fifth annual regulatory conference on optimising the development of advanced therapies to.

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Implant used to help new bone develop in patients with spinal disc problems and leg fractures .... E-mail [email protected] Website www.ema.europa.eu.

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a desktop news reader. For a list of RSS readers please refer to ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

Agenda - European Medicines Agency - europa.eu
Jun 18, 2018 - 27. 7.8.1. List of all applications submitted/expected and the COMP coordinatorship distribution of .... 5,10-dihydrodibenzo[b,e][1,4] diazepin-11-one, EMA/OD/031/10 Glutathione-pegylated ...... Abbreviations / Acronyms.

Committee_Meeting dates_2017 - European Medicines Agency
Sep 26, 2016 - An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.